| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 40.125 | 38.060 | 27.661 | 29.010 | 30.313 | 37.864 | 43.923 | 56.904 | 37.020 |
| Total Income - EUR | - | 40.125 | 38.064 | 27.661 | 29.010 | 30.313 | 37.864 | 43.923 | 57.915 | 41.658 |
| Total Expenses - EUR | - | 37.647 | 36.291 | 28.655 | 29.103 | 30.017 | 39.795 | 46.406 | 57.148 | 40.933 |
| Gross Profit/Loss - EUR | - | 2.477 | 1.773 | -994 | -93 | 296 | -1.931 | -2.483 | 767 | 725 |
| Net Profit/Loss - EUR | - | 1.362 | 1.315 | -1.384 | -632 | -212 | -2.097 | -2.923 | 188 | 308 |
| Employees | - | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Gaby Biofruct Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 2.322 | 3.937 | 2.120 | 1.361 | 1.686 | 591 | 1.244 | 3.026 | 971 |
| Inventories | - | 175 | 203 | 437 | 538 | 331 | 388 | 928 | 1.485 | 548 |
| Receivables | - | 18 | 15 | 243 | 0 | 0 | 0 | 0 | 0 | 1 |
| Cash | - | 2.129 | 3.718 | 1.440 | 822 | 1.355 | 203 | 316 | 1.541 | 423 |
| Shareholders Funds | - | 2.253 | 3.529 | 2.081 | 1.408 | 1.170 | -953 | -3.879 | -3.679 | -3.351 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 70 | 408 | 39 | 174 | 733 | 1.545 | 5.123 | 6.705 | 4.322 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4781 - 4781" | |||||||||
| CAEN Financial Year |
4781
|
|||||||||
Comments - Gaby Biofruct Srl